Trial intelligence / Profile preview

Sabin-strain Inactivated Poliovirus Vaccine (Vero Cell) in Infants

CTR20170982Phase 3Completed

Sponsor
Beijing Minhai Biological
Start
Aug 2017
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 3 trial of sabin-strain inactivated poliovirus vaccine (vero cell) in poliomyelitis, sponsored by Beijing Minhai Biological. Started Aug 2017; status: completed.

02

Drugs

sabin-strain inactivated poliovirus vaccine (vero cell)
03

Conditions

poliomyelitis

Beyond the preview

Go deeper on CTR20170982.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20170982.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call